Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Enzon Pharmaceuticals Inc

CUSIP: 293904958 | 3 institutional holders

Quarters

Q1 2016 Q4 2015 Q3 2015 Q2 2015 Q4 2014

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile